Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors
Abstract Response assessment in the context of immunomodulatory treatments represents a major challenge for the medical imaging community and requires a multidisciplinary approach with involvement of oncologists, radiologists, and nuclear medicine specialists. There is evolving evidence that [18F]FD...
Main Authors: | E. Lopci, N. Aide, A. Dimitrakopoulou-Strauss, L. Dercle, A. Iravani, R. D. Seban, C. Sachpekidis, O. Humbert, O. Gheysens, A. W. J. M. Glaudemans, W. A. Weber, A. D. Van den Abbeele, R. L. Wahl, A. M. Scott, N. Pandit-Taskar, R. J. Hicks |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Cancer Imaging |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40644-022-00512-z |
Similar Items
-
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC
by: Slart, R, et al.
Published: (2018) -
Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance
by: Lauri, C, et al.
Published: (2024) -
EANM guideline on the validation of analytical methods for radiopharmaceuticals
by: Nic Gillings, et al.
Published: (2020-02-01) -
EANM guidelines for PET-CT and PET-MR routine quality control
by: Michel Koole, et al.
Published: (2023-02-01) -
EANM procedural guidelines for myocardial perfusion scintigraphy using cardiac-centered gamma cameras
by: Fabien Hyafil, et al.
Published: (2019-07-01)